Dr Danielle M Salhany, DO - Medicare Obstetrics/gynecology in Augusta, ME

Dr Danielle M Salhany, DO is a medicare enrolled "Obstetrics & Gynecology" physician in Augusta, Maine. She went to University Of New England, College Of Osteo Medicine and graduated in 2005 and has 19 years of diverse experience with area of expertise as Obstetrics/gynecology. She is a member of the group practice Mainehealth and her current practice location is 5 Caldwell Rd, Kennebec Valley Ob/gyn, Augusta, Maine. You can reach out to her office (for appointments etc.) via phone at (207) 623-1322.

Dr Danielle M Salhany is licensed to practice in Maine (license number DO2117) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1689742520.

Contact Information

Dr Danielle M Salhany, DO
5 Caldwell Rd, Kennebec Valley Ob/gyn,
Augusta, ME 04330-5739
(207) 623-1322
(207) 623-1462



Physician's Profile

Full NameDr Danielle M Salhany
GenderFemale
SpecialityObstetrics/gynecology
Experience19 Years
Location5 Caldwell Rd, Augusta, Maine
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Danielle M Salhany attended and graduated from University Of New England, College Of Osteo Medicine in 2005
  NPI Data:
  • NPI Number: 1689742520
  • Provider Enumeration Date: 11/30/2006
  • Last Update Date: 06/29/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 1658556386
  • Enrollment ID: I20110425000050

Medical Identifiers

Medical identifiers for Dr Danielle M Salhany such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1689742520NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology T0630 (Maine)Secondary
207V00000XObstetrics & Gynecology DO2117 (Maine)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Mid Coast HospitalBrunswick, MEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Mainehealth75178605882067

News Archive

Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses

At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports.

Eating oat fibre can reduce three markers linked to cardiovascular risk

Researchers have known for more than 50 years that eating oats can lower cholesterol levels and thus reduce a person's risk of developing cardiovascular disease.

Weighing risks and benefits of antidepressant medication for older adults

Depression is a common and serious problem for older adults. Some 15 to 20 percent of people aged 65 and older who live independently deal with symptoms of major depressive disorder.

Thomas the Tank Engine in trouble!

In the latest scare over products from China a popular line of children's toys has been recalled.

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Danielle M Salhany allows following entities to bill medicare on her behalf.
Entity NameMainegeneral Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669423380
PECOS PAC ID: 1254245715
Enrollment ID: O20031118000718

News Archive

Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses

At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports.

Eating oat fibre can reduce three markers linked to cardiovascular risk

Researchers have known for more than 50 years that eating oats can lower cholesterol levels and thus reduce a person's risk of developing cardiovascular disease.

Weighing risks and benefits of antidepressant medication for older adults

Depression is a common and serious problem for older adults. Some 15 to 20 percent of people aged 65 and older who live independently deal with symptoms of major depressive disorder.

Thomas the Tank Engine in trouble!

In the latest scare over products from China a popular line of children's toys has been recalled.

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

Read more Medical News

› Verified 5 days ago

Entity NameMid Coast Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1932164795
PECOS PAC ID: 5496739468
Enrollment ID: O20040623001212

News Archive

Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses

At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports.

Eating oat fibre can reduce three markers linked to cardiovascular risk

Researchers have known for more than 50 years that eating oats can lower cholesterol levels and thus reduce a person's risk of developing cardiovascular disease.

Weighing risks and benefits of antidepressant medication for older adults

Depression is a common and serious problem for older adults. Some 15 to 20 percent of people aged 65 and older who live independently deal with symptoms of major depressive disorder.

Thomas the Tank Engine in trouble!

In the latest scare over products from China a popular line of children's toys has been recalled.

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

Read more Medical News

› Verified 5 days ago

Entity NameMainehealth
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790265502
PECOS PAC ID: 7517860588
Enrollment ID: O20040701000166

News Archive

Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses

At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports.

Eating oat fibre can reduce three markers linked to cardiovascular risk

Researchers have known for more than 50 years that eating oats can lower cholesterol levels and thus reduce a person's risk of developing cardiovascular disease.

Weighing risks and benefits of antidepressant medication for older adults

Depression is a common and serious problem for older adults. Some 15 to 20 percent of people aged 65 and older who live independently deal with symptoms of major depressive disorder.

Thomas the Tank Engine in trouble!

In the latest scare over products from China a popular line of children's toys has been recalled.

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

Read more Medical News

› Verified 5 days ago

Entity NameMainegeneral Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063716710
PECOS PAC ID: 1254245715
Enrollment ID: O20110408000034

News Archive

Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses

At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports.

Eating oat fibre can reduce three markers linked to cardiovascular risk

Researchers have known for more than 50 years that eating oats can lower cholesterol levels and thus reduce a person's risk of developing cardiovascular disease.

Weighing risks and benefits of antidepressant medication for older adults

Depression is a common and serious problem for older adults. Some 15 to 20 percent of people aged 65 and older who live independently deal with symptoms of major depressive disorder.

Thomas the Tank Engine in trouble!

In the latest scare over products from China a popular line of children's toys has been recalled.

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Danielle M Salhany is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Danielle M Salhany, DO
5 Caldwell Rd, Kennebec Valley Ob/gyn,
Augusta, ME 04330-5739

Ph: (207) 623-1322
Dr Danielle M Salhany, DO
5 Caldwell Rd, Kennebec Valley Ob/gyn,
Augusta, ME 04330-5739

Ph: (207) 623-1322

News Archive

Scientists at retrovirus conference present findings on microbicide gel, Truvada, male circumcision, ART care by nurses

At the annual Conference on Retroviruses and Opportunistic Infections (CROI) in Boston on Monday, researchers "suggested the potential" of a gel containing the antiretroviral drug tenofovir to reduce the risk of anal HIV transmission, TIME's "Healthland" blog reports.

Eating oat fibre can reduce three markers linked to cardiovascular risk

Researchers have known for more than 50 years that eating oats can lower cholesterol levels and thus reduce a person's risk of developing cardiovascular disease.

Weighing risks and benefits of antidepressant medication for older adults

Depression is a common and serious problem for older adults. Some 15 to 20 percent of people aged 65 and older who live independently deal with symptoms of major depressive disorder.

Thomas the Tank Engine in trouble!

In the latest scare over products from China a popular line of children's toys has been recalled.

Enzon Pharmaceuticals initiates treatment in PEG-SN38 Phase 1 study for pediatric cancer patients

Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.

Read more News

› Verified 5 days ago


Obstetrics & Gynecology Doctors in Augusta, ME

Dr. Monica Jenette Tschirhart, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330
Phone: 207-621-9100    
Hishalah Zvulon, M.D.
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 5 Caldwell Rd, Augusta, ME 04330
Phone: 207-623-1322    Fax: 207-623-1462
Carrie L. Bolander, D.O.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 15 E Chestnut St, Augusta, ME 04330
Phone: 207-626-1561    Fax: 207-626-1849
Donald J Mccrann Jr., MD
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 15 E Chestnut St, Augusta, ME 04330
Phone: 207-626-1561    Fax: 207-626-1849
Glenn D. Gianini, D.O.
Obstetrics & Gynecology
Medicare: Not Enrolled in Medicare
Practice Location: 5 Caldwell Rd, Augusta, ME 04330
Phone: 207-623-1322    
Kathleen B Petersen, MD
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 5 Caldwell Rd, Augusta, ME 04330
Phone: 207-623-1322    
Karen J Bossie, DO
Obstetrics & Gynecology
Medicare: Medicare Enrolled
Practice Location: 35 Medical Center Pkwy Ste 202, Augusta, ME 04330
Phone: 207-623-3790    Fax: 207-623-3629

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.